How to buy Eton Pharmaceuticals stock (ETON)

Eton Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. Eton Pharmaceuticals shares (ETON) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.57 – an increase of 1.78% over the previous week. Eton Pharmaceuticals employs 30 staff and has a trailing 12-month revenue of around $31.4 million.

Our top picks for where to buy Eton Pharmaceuticals stock

Buy Eton Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Eton Pharmaceuticals stock price (NASDAQ: ETON)

Use our graph to track the performance of ETON stocks over time.

Eton Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$12.57
52-week range	$3.03 - $13.98
50-day moving average more info button	$6.96
200-day moving average more info button	$4.59
Wall St. target price	$13.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.26

Is it a good time to buy Eton Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eton Pharmaceuticals price performance over time

Historical closes compared with the close of $12.57 from 2024-12-20

1 week (2024-12-13)	1.78%
1 month (2024-11-22)	11.93%
3 months (2024-09-20)	131.92%
6 months (2024-06-21)	276.35%

1 year (2023-12-22)	173.86%
2 years (2022-12-22)	321.81%
3 years (2021-12-22)	200.00%
5 years (2019-12-20)	82.17%

Eton Pharmaceuticals financials

Revenue TTM	$31.4 million
Gross profit TTM	$14.3 million
Return on assets TTM	-12.5%
Return on equity TTM	-44.3%
Profit margin	-21.31%
Book value	$0.52
Market Capitalization more info button	$236.9 million

TTM: trailing 12 months

Eton Pharmaceuticals share dividends

We're not expecting Eton Pharmaceuticals to pay a dividend over the next 12 months.

Eton Pharmaceuticals share price volatility

Over the last 12 months, Eton Pharmaceuticals's shares have ranged in value from as little as $3.03 up to $13.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eton Pharmaceuticals's is 1.257. This would suggest that Eton Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Eton Pharmaceuticals overview

Eton Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. .

Frequently asked questions

null
What percentage of Eton Pharmaceuticals is owned by insiders or institutions?
Currently 5.386% of Eton Pharmaceuticals shares are held by insiders and 33.238% by institutions. How many people work for Eton Pharmaceuticals?
Latest data suggests 30 work at Eton Pharmaceuticals. When does the fiscal year end for Eton Pharmaceuticals?
Eton Pharmaceuticals's fiscal year ends in December. Where is Eton Pharmaceuticals based?
Eton Pharmaceuticals's address is: 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278 What is Eton Pharmaceuticals's ISIN number?
Eton Pharmaceuticals's international securities identification number is: US29772L1089 What is Eton Pharmaceuticals's CUSIP number?
Eton Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29772L108